Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Tracon Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Tracon Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Brown Scott B. | CHIEF FINANCIAL OFFICER | 25,128 | Mar 13, 2024 | 0 |
| Theuer Charles | PRESIDENT AND CEO | 406,417 | Mar 13, 2024 | 0 |
| Opaleye Management Inc. | 10% Owner | 0Indirect | Nov 14, 2023 | 0 |
| Pelletier Saundra L | Director | 12,045 | Apr 21, 2023 | 0 |
| Mattingly Martin A | Director | – | Apr 21, 2023 | 0 |
| Larue William R | Director | 7,763 | Apr 21, 2023 | 0 |
| Worland Stephen T | Director | – | Apr 21, 2023 | 0 |
| Twiford J Rainer | Director | – | Apr 21, 2023 | 0 |
| Lam Carol C. | Director | – | Apr 21, 2023 | 0 |
| Johnson-Pratt Lisa | Director | – | Apr 21, 2023 | 0 |
| Adams Bonne J. | Chief Operating Officer | – | Feb 9, 2023 | 0 |
| Wiggins Mark C | Chief Business Officer | – | Feb 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 (view filing) | Dec 13-14 | 2 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +57.2K | $2.56 | +$146.4K | +29.6%250.7K after | 4 lots |
| Dec 7, 2021 (view filing) | Dec 3-6 | 4 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +112.0K | $2.29 | +$256.7K | +85.8%242.5K after | 4 lots |
| Dec 3, 2021 (view filing) | Dec 1-2 | 2 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +60.5K | $2.39 | +$144.7K | +35.6%230.5K after | 4 lots |
| Nov 22, 2021 (view filing) | Nov 18-19 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +4.18K | $2.83 | +$11.8K | +1.9%219.3K after | 2 lots |
| Nov 9, 2021 (view filing) | Nov 5 | 4 days | Theuer CharlesPresident and CEO | PPurchase | +4.00K | $3.42 | +$13.7K | +1.9%215.1K after | 2 lots |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Theuer CharlesPresident and CEO | PPurchase | +3.00K | $3.56 | +$10.7K | +1.5%207.7K after | |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Brown Scott B.Chief Financial Officer | PPurchase | +1.00K | $3.69 | +$3.69K | +15.1%7.63K after | |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Pelletier Saundra LDirector | PPurchase | +6.54K | $3.82 | +$25.0K | +119.0%12.0K after | |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Larue William RDirector | PPurchase | +6.54K | $3.82 | +$25.0K | +489.2%7.88K after |